406 related articles for article (PubMed ID: 31843811)
1. Inflammation and atherosclerosis: what is on the horizon?
Ruparelia N; Choudhury R
Heart; 2020 Jan; 106(1):80-85. PubMed ID: 31843811
[No Abstract] [Full Text] [Related]
2. Novel anti-inflammatory therapies for the treatment of atherosclerosis.
Khan R; Spagnoli V; Tardif JC; L'Allier PL
Atherosclerosis; 2015 Jun; 240(2):497-509. PubMed ID: 25917947
[TBL] [Abstract][Full Text] [Related]
3. Atherosclerosis is a major human killer and non-resolving inflammation is a prime suspect.
Fredman G; MacNamara KC
Cardiovasc Res; 2021 Nov; 117(13):2563-2574. PubMed ID: 34609505
[TBL] [Abstract][Full Text] [Related]
4. Targeting the immune response in atherosclerosis: It's time for clinical trials!
Joffre J; Ait-Oufella H
Arch Cardiovasc Dis; 2017 Dec; 110(12):643-645. PubMed ID: 29051009
[No Abstract] [Full Text] [Related]
5. Atherosclerosis and autoimmunity: a growing relationship.
Sanjadi M; Rezvanie Sichanie Z; Totonchi H; Karami J; Rezaei R; Aslani S
Int J Rheum Dis; 2018 May; 21(5):908-921. PubMed ID: 29671956
[TBL] [Abstract][Full Text] [Related]
6. Exploring immune checkpoints as potential therapeutic targets in atherosclerosis.
Kusters PJH; Lutgens E; Seijkens TTP
Cardiovasc Res; 2018 Mar; 114(3):368-377. PubMed ID: 29309533
[TBL] [Abstract][Full Text] [Related]
7. The Utility of Anti-Inflammatory Agents in Cardiovascular Disease: A Novel Perspective on the Treatment of Atherosclerosis.
Kottoor SJ; Arora RR
J Cardiovasc Pharmacol Ther; 2018 Nov; 23(6):483-493. PubMed ID: 29783850
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in therapeutic targeting of inflammation in atherosclerosis.
Hedin U; Matic LP
J Vasc Surg; 2019 Mar; 69(3):944-951. PubMed ID: 30591299
[TBL] [Abstract][Full Text] [Related]
9. Editorial: update on inflammatory targets modulating atherogenesis.
Carbone F; Mach F; Montecucco F
Curr Drug Targets; 2015; 16(4):282-3. PubMed ID: 25859799
[No Abstract] [Full Text] [Related]
10. Macrophages and dendritic cells: the usual suspects in atherogenesis.
Kassiteridi C; Monaco C
Curr Drug Targets; 2015; 16(4):373-82. PubMed ID: 25808566
[TBL] [Abstract][Full Text] [Related]
11. Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.
Raggi P; Genest J; Giles JT; Rayner KJ; Dwivedi G; Beanlands RS; Gupta M
Atherosclerosis; 2018 Sep; 276():98-108. PubMed ID: 30055326
[TBL] [Abstract][Full Text] [Related]
12. Functional diversity of macrophages in vascular biology and disease.
Park I; Kassiteridi C; Monaco C
Vascul Pharmacol; 2017 Dec; 99():13-22. PubMed ID: 29074468
[TBL] [Abstract][Full Text] [Related]
13. The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation.
MartÃnez GJ; Celermajer DS; Patel S
Atherosclerosis; 2018 Feb; 269():262-271. PubMed ID: 29352570
[TBL] [Abstract][Full Text] [Related]
14. 2016 Jeffrey M. Hoeg Award Lecture.
Rouwet E; Lutgens E
Arterioscler Thromb Vasc Biol; 2018 Aug; 38(8):1678-1688. PubMed ID: 29930003
[TBL] [Abstract][Full Text] [Related]
15. Polydatin for treating atherosclerotic diseases: A functional and mechanistic overview.
Wu M; Li X; Wang S; Yang S; Zhao R; Xing Y; Liu L
Biomed Pharmacother; 2020 Aug; 128():110308. PubMed ID: 32480216
[TBL] [Abstract][Full Text] [Related]
16. S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.
Oesterle A; Bowman MA
Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2496-507. PubMed ID: 26515415
[TBL] [Abstract][Full Text] [Related]
17. Anti-inflammatory effects of sodium-glucose co-transporter 2 inhibitors on atherosclerosis.
Kang Y; Zhan F; He M; Liu Z; Song X
Vascul Pharmacol; 2020; 133-134():106779. PubMed ID: 32814163
[TBL] [Abstract][Full Text] [Related]
18. Atherosclerosis and immunity: A perspective.
Abdolmaleki F; Gheibi Hayat SM; Bianconi V; Johnston TP; Sahebkar A
Trends Cardiovasc Med; 2019 Aug; 29(6):363-371. PubMed ID: 30292470
[TBL] [Abstract][Full Text] [Related]
19. The Characteristics and Roles of Advanced Oxidation Protein Products in Atherosclerosis.
Ou H; Huang Z; Mo Z; Xiao J
Cardiovasc Toxicol; 2017 Jan; 17(1):1-12. PubMed ID: 27350146
[TBL] [Abstract][Full Text] [Related]
20. Update on the role of neutrophils in atherosclerotic plaque vulnerability.
Carbone F; Mach F; Montecucco F
Curr Drug Targets; 2015; 16(4):321-33. PubMed ID: 25382205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
